Natixis CIB Closes USD120mn Hybrid Facility for R-Bridge Healthcare Fund

Hong Kong, March 8, 2023

Natixis Corporate & Investment Banking recently closed a USD 120 million hybrid facility for R-Bridge Healthcare Fund, LP.

R-Bridge Healthcare Fund, LP (“RBF”) is managed by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore. RBF provides leading biotech, biopharma, medical technology, and healthcare services companies with bespoke, non-dilutive financing, backed by Asia-sourced healthcare royalty / revenue interests, or through a range of alternative financing structures. 

The closing of this hybrid facility follows the repayment in full of the previous vanilla subscription facility. With a hybrid structure, the newly closed facility relies on both recallable and uncalled capital from investors of RBF and the performance of the investments made by RBF.

Nicholas Low, Head of Healthcare Industry Group, Asia Pacific from Natixis CIB commented:We are delighted to have supported CBC Group with their latest facility for the RBF. Natixis CIB is focused on providing innovative and bespoke solutions for our clients. This hybrid structure has been specifically designed to meet RBF’s financing needs at an optimized all-in cost and to support CBC Group in delivering performance and flexibility to its clients while pursuing their ambitions to invest in better access to affordable healthcare.

RBF was advised by Sidley Austin LLP, as lead counsel and Maples and Calder (Hong Kong) LLP as Cayman Islands legal counsel.

Natixis CIB was advised by Reed Smith LLP, as lead counsel and Mourant Ozannes (Hong Kong) LLP as Cayman Islands legal counsel.